Brynn Levy Elected President of the ACMG Foundation for Genetic and Genomic Medicine
Harry Ostrer has been named president-elect, while Nancy Mendelsohn assumes the role of past president following the completion of her term.
Harry Ostrer has been named president-elect, while Nancy Mendelsohn assumes the role of past president following the completion of her term.
A University of Warwick study finds AI cancer detection models may rely on statistical correlations rather than true biomarker signals, raising concerns about reliability in clinical pathology applications.
The Menlo Park-based company is integrating epigenetic signatures into its rare disease diagnostics offering, with the new capability set to roll out automatically in early Q2 2026.
The AI companion analyzes up to five years of personal lab data within the company's patient portal to explain test results and identify health trends.
20/20 BioLabs argues a tiered screening approach—starting with protein-based tests before moving to circulating tumor DNA testing or imaging—could improve early-stage detection and lower costs.